U.S. government orders IV versions of two flu drugs to treat hospitalized patients.
11/06/09 - 06:29 AM EST
Alkermes Takes 2Q Loss, Cuts Full-year Estimates
Alkermes reports loss, and expects lower Risperdal Consta and Vivitrol revenue in fiscal 2010
11/05/09 - 06:48 PM EST
BioCryst Winners and Losers: BioBuzz
Sorting out the latest salvo in the H1N1 investor war
11/05/09 - 02:32 PM EST
BioCryst Ships Flu Drug to U.S. Government: BioBuzz
- Tickers in this article:
- BCRX
Initial order lower than expected but priced higher
11/05/09 - 08:03 AM EST
Cel-Sci's Lawyer Speaks: BioBuzz
Cel-Sci's complaint avoids the central issue about its mystery South African partner.
11/05/09 - 10:40 AM EST
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Cisco, Tessera and ImmunoGen.
11/05/09 - 08:06 AM EST
Acne, Wrinkle Treatments Help Medicis Post Profit
- Tickers in this article:
- MRX
Medicis reports profit as sales pick up and charges decrease; company raises 2009 forecasts
11/04/09 - 06:21 PM EST
Hemispherx Cops to Ampligen FDA Delay
Disclosure raises questions about the veracity of CEO's past statements.
11/03/09 - 07:47 AM EST
Cel-Sci's South Africa Partner a Mystery
- Tickers in this article:
- CVM
Little information is available about Byron Biopharma, which was incorporated just days before its marketing deal with Cel-Sci was announced.
11/04/09 - 10:23 AM EST
Cel-Sci Booster's Identity in Question
- Tickers in this article:
- CVM
An article lauding Cel-Sci's H1N1 drug is in question because it appears its author may not be who he says he is.
10/06/09 - 12:24 PM EDT
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Celgene, Research In Motion and Berkshire Hathaway.
11/04/09 - 08:26 AM EST
Merck Completes $41B Purchase Of Schering-Plough
Merck is set to close $41B purchase of Schering-Plough, becoming world's No. 2 drugmaker
11/03/09 - 11:50 AM EST
Connect with TheStreet